156 related articles for article (PubMed ID: 32793574)
1. Expression Profiling and Glycan Engineering of IgG Subclass 1-4 in
Kallolimath S; Hackl T; Gahn R; Grünwald-Gruber C; Zich W; Kogelmann B; Lux A; Nimmerjahn F; Steinkellner H
Front Bioeng Biotechnol; 2020; 8():825. PubMed ID: 32793574
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer.
Wieczorek M; Braicu EI; Oliveira-Ferrer L; Sehouli J; Blanchard V
Front Immunol; 2020; 11():654. PubMed ID: 32477323
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum.
Wuhrer M; Stam JC; van de Geijn FE; Koeleman CA; Verrips CT; Dolhain RJ; Hokke CH; Deelder AM
Proteomics; 2007 Nov; 7(22):4070-81. PubMed ID: 17994628
[TBL] [Abstract][Full Text] [Related]
4. The association between subclass-specific IgG Fc N-glycosylation profiles and hypertension in the Uygur, Kazak, Kirgiz, and Tajik populations.
Liu JN; Dolikun M; Štambuk J; Trbojević-Akmačić I; Zhang J; Wang H; Zheng DQ; Zhang XY; Peng HL; Zhao ZY; Liu D; Sun Y; Sun Q; Li QH; Zhang JX; Sun M; Cao WJ; Momčilović A; Razdorov G; Wu LJ; Russell A; Wang YX; Song MS; Lauc G; Wang W
J Hum Hypertens; 2018 Sep; 32(8-9):555-563. PubMed ID: 29867134
[TBL] [Abstract][Full Text] [Related]
5. Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies.
Sonneveld ME; Koeleman CAM; Plomp HR; Wuhrer M; van der Schoot CE; Vidarsson G
Front Immunol; 2018; 9():129. PubMed ID: 29445378
[TBL] [Abstract][Full Text] [Related]
6. IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.
Lundström SL; Fernandes-Cerqueira C; Ytterberg AJ; Ossipova E; Hensvold AH; Jakobsson PJ; Malmström V; Catrina AI; Klareskog L; Lundberg K; Zubarev RA
PLoS One; 2014; 9(11):e113924. PubMed ID: 25426976
[TBL] [Abstract][Full Text] [Related]
7. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
8. Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health.
Plomp R; Ruhaak LR; Uh HW; Reiding KR; Selman M; Houwing-Duistermaat JJ; Slagboom PE; Beekman M; Wuhrer M
Sci Rep; 2017 Sep; 7(1):12325. PubMed ID: 28951559
[TBL] [Abstract][Full Text] [Related]
9. Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity.
Peschke B; Keller CW; Weber P; Quast I; Lünemann JD
Front Immunol; 2017; 8():646. PubMed ID: 28634480
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of the Man5 glycoform of human IgG3 Fc.
Shah IS; Lovell S; Mehzabeen N; Battaile KP; Tolbert TJ
Mol Immunol; 2017 Dec; 92():28-37. PubMed ID: 29031045
[TBL] [Abstract][Full Text] [Related]
11. Engineering of sialylated mucin-type O-glycosylation in plants.
Castilho A; Neumann L; Daskalova S; Mason HS; Steinkellner H; Altmann F; Strasser R
J Biol Chem; 2012 Oct; 287(43):36518-26. PubMed ID: 22948156
[TBL] [Abstract][Full Text] [Related]
12. Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs.
Lund J; Takahashi N; Nakagawa H; Goodall M; Bentley T; Hindley SA; Tyler R; Jefferis R
Mol Immunol; 1993 Jun; 30(8):741-8. PubMed ID: 8502242
[TBL] [Abstract][Full Text] [Related]
13. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.
Castilho A; Gruber C; Thader A; Oostenbrink C; Pechlaner M; Steinkellner H; Altmann F
MAbs; 2015; 7(5):863-70. PubMed ID: 26067753
[TBL] [Abstract][Full Text] [Related]
14. The
de Haan N; Reiding KR; Krištić J; Hipgrave Ederveen AL; Lauc G; Wuhrer M
Front Immunol; 2017; 8():608. PubMed ID: 28620376
[No Abstract] [Full Text] [Related]
15. Glycomics for Type 2 Diabetes Biomarker Discovery: Promise of Immunoglobulin G Subclass-Specific Fragment Crystallizable N-glycosylation in the Uyghur Population.
Liu J; Dolikun M; Štambuk J; Trbojević-Akmačić I; Zhang J; Zhang J; Wang H; Meng X; Razdorov G; Menon D; Zheng D; Wu L; Wang Y; Song M; Lauc G; Wang W
OMICS; 2019 Dec; 23(12):640-648. PubMed ID: 31393219
[TBL] [Abstract][Full Text] [Related]
16. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
[TBL] [Abstract][Full Text] [Related]
17. Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities.
Dekkers G; Treffers L; Plomp R; Bentlage AEH; de Boer M; Koeleman CAM; Lissenberg-Thunnissen SN; Visser R; Brouwer M; Mok JY; Matlung H; van den Berg TK; van Esch WJE; Kuijpers TW; Wouters D; Rispens T; Wuhrer M; Vidarsson G
Front Immunol; 2017; 8():877. PubMed ID: 28824618
[TBL] [Abstract][Full Text] [Related]
18. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
[TBL] [Abstract][Full Text] [Related]
19. Production and
Nguyen KD; Kajiura H; Kamiya R; Yoshida T; Misaki R; Fujiyama K
Front Plant Sci; 2023; 14():1215580. PubMed ID: 37615027
[No Abstract] [Full Text] [Related]
20. Modulating IgG effector function by Fc glycan engineering.
Li T; DiLillo DJ; Bournazos S; Giddens JP; Ravetch JV; Wang LX
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3485-3490. PubMed ID: 28289219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
